Hindié E, Mesguich C, Bouabdallah K, Milpied N. Response to the letter by Adams and Kwee, entitled: “Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma”.
Eur J Nucl Med Mol Imaging 2017;
44:1937-1939. [DOI:
10.1007/s00259-017-3773-6]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]